|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 927.03 USD | +2.55% |
|
-1.32% | -13.74% |
| 04-18 | Health Care Up Ahead of Earnings - Health Care Roundup | DJ |
| 04-17 | Kailera makes a splash on Nasdaq as anti-obesity drug frenzy continues |  |
| Capitalization | 830B 703B 647B 612B 1,134B 76,757B 1,154B 7,572B 2,969B 37,208B 3,112B 3,047B 131,139B | P/E ratio 2026 * |
27.3x | P/E ratio 2027 * | 23x |
|---|---|---|---|---|---|
| Enterprise value | 845B 716B 659B 624B 1,156B 78,229B 1,176B 7,717B 3,026B 37,921B 3,171B 3,105B 133,653B | EV / Sales 2026 * |
10.3x | EV / Sales 2027 * | 8.68x |
| Free-Float |
99.81% | Yield 2026 * |
0.73% | Yield 2027 * | 0.81% |
Last Transcript: Eli Lilly and Company
| 1 day | +2.55% | ||
| 1 week | -1.32% | ||
| Current month | +0.79% | ||
| 1 month | +0.98% | ||
| 3 months | -10.73% | ||
| 6 months | +15.47% | ||
| Current year | -13.74% |
| 1 week | 888.03 |  | 945.9 |
| 1 month | 877.11 | | 976.68 |
| Current year | 877.11 | | 1,133.95 |
| 1 year | 623.78 | | 1,133.95 |
| 3 years | 369.76 | | 1,133.95 |
| 5 years | 178.58 | | 1,133.95 |
| 10 years | 64.18 | | 1,133.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Ricks
CEO | Chief Executive Officer | 58 | 01/01/2017 |
Lucas Montarce
DFI | Director of Finance/CFO | 49 | 09/09/2024 |
| Chief Tech/Sci/R&D Officer | 52 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Jon Fyrwald
BRD | Director/Board Member | 65 | 01/01/2005 |
Ralph Alvarez
BRD | Director/Board Member | 69 | 01/04/2009 |
| Director/Board Member | 54 | 12/12/2011 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +1.55% | 6.49% | 26 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.55% | -1.32% | +10.37% | +150.61% | 830B | |
| -0.15% | -1.79% | +48.71% | +45.44% | 564B | |
| -0.29% | +0.21% | +20.46% | +30.57% | 369B | |
| +2.07% | +1.39% | +25.20% | +15.80% | 328B | |
| +1.72% | -0.74% | +49.33% | +25.56% | 318B | |
| +3.13% | -1.94% | +52.65% | +3.69% | 294B | |
| +1.19% | -2.41% | +31.10% | +35.44% | 291B | |
| +1.69% | +1.22% | +28.13% | +44.38% | 192B | |
| +1.24% | +8.21% | -38.18% | -54.92% | 182B | |
| -0.66% | -0.97% | +31.66% | +64.29% | 171B | |
| Average | +1.25% | +0.03% | +25.94% | +36.09% | 353.84B | |
| Weighted average by Cap. | +1.37% | -0.64% | +27.11% | +55.40% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 81.87B 69.35B 63.81B 60.39B 112B 7,575B 114B 747B 293B 3,672B 307B 301B 12,942B | 95.06B 80.52B 74.09B 70.12B 130B 8,796B 132B 868B 340B 4,264B 357B 349B 15,027B |
| Net income | 30.36B 25.71B 23.66B 22.39B 41.5B 2,809B 42.23B 277B 109B 1,362B 114B 111B 4,799B | 35.99B 30.48B 28.05B 26.55B 49.2B 3,330B 50.06B 329B 129B 1,614B 135B 132B 5,689B |
| Net Debt | 15.9B 13.47B 12.39B 11.73B 21.74B 1,471B 22.12B 145B 56.91B 713B 59.64B 58.4B 2,514B | -4.83B -4.09B -3.76B -3.56B -6.6B -447B -6.72B -44.08B -17.28B -217B -18.11B -17.74B -763B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/04/26 | 927.03 $ | +2.55% | 3,266,094 |
| 16/04/26 | 903.99 $ | -0.11% | 2,836,574 |
| 15/04/26 | 905.03 $ | -1.89% | 4,233,418 |
| 14/04/26 | 922.50 $ | -0.76% | 2,360,236 |
| 13/04/26 | 929.55 $ | -1.06% | 2,089,567 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- LLY Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition